SCHEMBL6435640

SCHEMBL6435640

C=CCC(C(=O)c1ccc2ccccc2c1)C(=O)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.47
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
MEN1 O00255 1/20 0.47
EGFR P00533 1/20 0.47
TP53 P04637 1/20 0.47
CYP3A4 P08684 1/20 0.47
MAPT P10636 1/20 0.47
PKM P14618 1/20 0.47
ALOX15 P16050 1/20 0.47
ALOX12 P18054 1/20 0.47
JAK1 P23458 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
HSD17B10 Q99714 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PTPN1 P18031 1/20 0.43
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6885500 0.75 CES2 (0.49) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL10457332 0.71 GRIK1 (0.32) ALDH1A1SMN1; SMN2
SCHEMBL6135938 0.70 CYP2C19 (0.46) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL13898262 0.70 POLB (0.42) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL8192813 0.70 MEN1 (0.46) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL9575208 0.69 KDM4E (0.68) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL29645049 0.68 CES1 (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL10975235 0.68 MDM2 (0.55) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL12699944 0.68 CES2 (0.67) KDM4EALDH1A1HPGDSMN1; SMN2MEN1
SCHEMBL4307207 0.68 CES1 (0.61) KDM4EALDH1A1HPGDSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050011405-A1 Red fluorescent material and composition containing the same NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050011405-A1 Red fluorescent material and composition containing the same IK, HNRNPL, HNRNPA0 KDM4E 2760/4885ALDH1A1 369/4885HPGD 4038/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.